Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CYP2A6 anticorps (C-Term)

CYP2A6 Reactivité: Humain WB, ELISA, IF, IHC (p) Hôte: Souris Monoclonal F16 P2 D8 unconjugated
N° du produit ABIN533615
  • Antigène Voir toutes CYP2A6 Anticorps
    CYP2A6 (Cytochrome P450, Family 2, Subfamily A, Polypeptide 6 (CYP2A6))
    Épitope
    • 15
    • 6
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reactivité
    • 43
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 37
    • 6
    Souris
    Clonalité
    • 38
    • 5
    Monoclonal
    Conjugué
    • 25
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CYP2A6 est non-conjugé
    Application
    • 38
    • 14
    • 13
    • 13
    • 7
    • 6
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Fonction
    Mouse monoclonal antibody raised against synthetic peptide of CYP2A6.
     Réactivité croisée
    Humain
    Attributs du produit
    Antibody Reactive Against Synthetic Peptide.
    Immunogène
    A synthetic peptide corresponding to C-terminus of human CYP2A6.
    Clone
    F16 P2 D8
    Isotype
    IgG1
    Top Product
    Discover our top product CYP2A6 Anticorps primaire
  • Indications d'application
    Western Blot (1-2 μg/mL)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In PBS (0.08 % sodium azide)
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Higashi, Nakajima, Katoh, Tokudome, Yokoi: "Inhibitory effects of neurotransmitters and steroids on human CYP2A6." dans: Drug metabolism and disposition: the biological fate of chemicals, Vol. 35, Issue 4, pp. 508-14, (2007) (PubMed).

    Audrain-McGovern, Al Koudsi, Rodriguez, Wileyto, Shields, Tyndale: "The role of CYP2A6 in the emergence of nicotine dependence in adolescents." dans: Pediatrics, Vol. 119, Issue 1, pp. e264-74, (2007) (PubMed).

    Swan, Benowitz, Lessov, Jacob, Tyndale, Wilhelmsen: "Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence." dans: Pharmacogenetics and genomics, Vol. 15, Issue 2, pp. 115-25, (2005) (PubMed).

  • Antigène
    CYP2A6 (Cytochrome P450, Family 2, Subfamily A, Polypeptide 6 (CYP2A6))
    Autre désignation
    CYP2A6 (CYP2A6 Produits)
    Synonymes
    anticorps CPA6, anticorps CYP2A, anticorps CYP2A3, anticorps CYPIIA6, anticorps P450C2A, anticorps P450PB, anticorps cyp2a6, anticorps cytochrome P450 family 2 subfamily A member 6, anticorps cytochrome P450 2A6, anticorps cytochrome P450 family 2 subfamily A member 6 L homeolog, anticorps CYP2A6, anticorps cyp2a6.L
    ID gène
    1548
Vous êtes ici:
Support technique